Bharvin K.R. Patel

1.7k total citations
29 papers, 1.1k citations indexed

About

Bharvin K.R. Patel is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Bharvin K.R. Patel has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Bharvin K.R. Patel's work include Cytokine Signaling Pathways and Interactions (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cancer Mechanisms and Therapy (4 papers). Bharvin K.R. Patel is often cited by papers focused on Cytokine Signaling Pathways and Interactions (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cancer Mechanisms and Therapy (4 papers). Bharvin K.R. Patel collaborates with scholars based in United States, United Kingdom and Spain. Bharvin K.R. Patel's co-authors include William J. LaRochelle, Jacalyn H. Pierce, Nancy B. Stamm, Rosa A. Carrasco, Ling-Mei Wang, George Sandusky, Eric G. Marcusson, Philip W. Iversen, Karim A. Benhadji and Eunice Yuen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Bharvin K.R. Patel

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bharvin K.R. Patel United States 17 623 560 259 123 101 29 1.1k
Leonardo Mirandola United States 20 606 1.0× 439 0.8× 512 2.0× 188 1.5× 98 1.0× 58 1.1k
Naoki Watanabe Japan 21 527 0.8× 220 0.4× 380 1.5× 152 1.2× 124 1.2× 72 1.2k
Andrzej Ptasznik United States 22 767 1.2× 386 0.7× 437 1.7× 231 1.9× 137 1.4× 37 1.6k
Fatima Lekmine United States 14 692 1.1× 550 1.0× 496 1.9× 126 1.0× 98 1.0× 18 1.3k
Apollina Goel United States 18 639 1.0× 258 0.5× 138 0.5× 161 1.3× 110 1.1× 23 1.1k
Elisabeth Heere‐Ress Austria 16 732 1.2× 402 0.7× 231 0.9× 44 0.4× 80 0.8× 21 1.1k
Robert A. Olie Switzerland 16 1.1k 1.7× 361 0.6× 153 0.6× 120 1.0× 93 0.9× 26 1.3k
Liubov Zaritskaya United States 14 487 0.8× 310 0.6× 273 1.1× 108 0.9× 240 2.4× 18 1.1k
R.C. Rees United Kingdom 17 402 0.6× 382 0.7× 581 2.2× 68 0.6× 175 1.7× 29 1.4k
Anja Krippner‐Heidenreich United Kingdom 21 565 0.9× 229 0.4× 408 1.6× 56 0.5× 143 1.4× 32 1.0k

Countries citing papers authored by Bharvin K.R. Patel

Since Specialization
Citations

This map shows the geographic impact of Bharvin K.R. Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bharvin K.R. Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bharvin K.R. Patel more than expected).

Fields of papers citing papers by Bharvin K.R. Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bharvin K.R. Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bharvin K.R. Patel. The network helps show where Bharvin K.R. Patel may publish in the future.

Co-authorship network of co-authors of Bharvin K.R. Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Bharvin K.R. Patel. A scholar is included among the top collaborators of Bharvin K.R. Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bharvin K.R. Patel. Bharvin K.R. Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pont, Margot J., Tyler Hill, Gabriel O. Cole, et al.. (2019). γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma. Blood. 134(19). 1585–1597. 238 indexed citations
2.
Massard, Christophe, Jean‐Charles Soria, Ulrik Lassen, et al.. (2018). First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer. Annals of Oncology. 29(9). 1911–1917. 107 indexed citations
3.
Massard, Christophe, J.C. Soria, Ulrik Lassen, et al.. (2016). First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer. European Journal of Cancer. 69. S15–S15. 16 indexed citations
4.
Pant, Shubham, Suzanne F. Jones, Carla Kurkjian, et al.. (2016). A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer. European Journal of Cancer. 56. 1–9. 72 indexed citations
5.
Yuen, Eunice, Bharvin K.R. Patel, Claire Smith, et al.. (2016). Abstract CT048: Population pharmacokinetics and pharmacodynamics for an oral Notch inhibitor, LY3039478, in the first-in-man study. Cancer Research. 76(14_Supplement). CT048–CT048. 3 indexed citations
6.
Bender, Mark H., Hong Gao, Andrew Capen, et al.. (2013). Abstract 1131: Novel inhibitor of Notch signaling for the treatment of cancer.. Cancer Research. 73(8_Supplement). 1131–1131. 13 indexed citations
7.
Carrasco, Rosa A., Nancy B. Stamm, Eric G. Marcusson, et al.. (2011). Antisense Inhibition of Survivin Expression as a Cancer Therapeutic. Molecular Cancer Therapeutics. 10(2). 221–232. 102 indexed citations
8.
Callies, Sophie, Valérie André, Bharvin K.R. Patel, et al.. (2010). Integrated analysis of preclinical data to support the design of the first in man study of LY2181308, a second generation antisense oligonucleotide. British Journal of Clinical Pharmacology. 71(3). 416–428. 20 indexed citations
9.
Shih, Chuan, Guoxin Zhu, Harold B. Brooks, et al.. (2003). Studies on cyclin-dependent kinase inhibitors: indolo-[2,3-a]pyrrolo[3,4-c]carbazoles versus bis-indolylmaleimides. Bioorganic & Medicinal Chemistry Letters. 13(21). 3841–3846. 28 indexed citations
10.
Day, Regina M., et al.. (2002). Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways. Oncogene. 21(14). 2201–2211. 10 indexed citations
11.
Nelson, Stefanie A., John P. Aris, Bharvin K.R. Patel, & William J. LaRochelle. (2000). Multiple Growth Factor Induction of a Murine Early Response Gene That Complements a Lethal Defect in Yeast Ribosome Biogenesis. Journal of Biological Chemistry. 275(18). 13835–13841. 6 indexed citations
12.
Soldatenkov, Viatcheslav A., et al.. (1999). Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor. Oncogene. 18(27). 3954–3962. 72 indexed citations
13.
Kriebel, Paul, Bharvin K.R. Patel, Stefanie A. Nelson, Michael J. Grusby, & William J. LaRochelle. (1999). Consequences of Stat6 deletion on Sis/PDGF- and IL-4-induced proliferation and transcriptional activation in murine fibroblasts. Oncogene. 18(51). 7294–7302. 10 indexed citations
14.
Patel, Bharvin K.R., Jacalyn H. Pierce, & William J. LaRochelle. (1998). Regulation of interleukin 4-mediated signaling by naturally occurring dominant negative and attenuated forms of human Stat6. Proceedings of the National Academy of Sciences. 95(1). 172–177. 54 indexed citations
15.
Patel, Bharvin K.R., et al.. (1998). Localization of the Human Stat6 Gene to Chromosome 12q13.3–q14.1, a Region Implicated in Multiple Solid Tumors. Genomics. 52(2). 192–200. 31 indexed citations
16.
Beeler, John F., Bharvin K.R. Patel, Márcio F. Chedid, & William J. LaRochelle. (1997). Cloning and characterization of the mouse homolog of the human A6 gene. Gene. 193(1). 31–37. 8 indexed citations
17.
Patel, Bharvin K.R., Ling-Mei Wang, Mark Frankel, et al.. (1997). Jak1 Expression Is Required for Mediating Interleukin-4-induced Tyrosine Phosphorylation of Insulin Receptor Substrate and Stat6 Signaling Molecules. Journal of Biological Chemistry. 272(10). 6556–6560. 54 indexed citations
18.
Patel, Bharvin K.R., et al.. (1996). Stat6 and Jak1 Are Common Elements in Platelet-derived Growth Factor and Interleukin-4 Signal Transduction Pathways in NIH 3T3 Fibroblasts. Journal of Biological Chemistry. 271(36). 22175–22182. 70 indexed citations
19.
Patel, Bharvin K.R. & Usha N. Kasid. (1993). Nucleotide sequence analysis of c‐raf‐1 cDNA and promoter from a radiation‐resistant human squamous carcinoma cell line: Deletion within exon 17. Molecular Carcinogenesis. 8(1). 7–12. 9 indexed citations
20.
Patel, et al.. (1974). P-phenylenediamine-mediated peroxidase deficiency in English setters with neuronal ceroid-lipofuscinosis.. PubMed. 30(3). 366–8. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leonardo Mirandola Breakdown of academic impact, for papers by Naoki Watanabe Breakdown of academic impact, for papers by Andrzej Ptasznik Breakdown of academic impact, for papers by Fatima Lekmine Breakdown of academic impact, for papers by Apollina Goel Breakdown of academic impact, for papers by Elisabeth Heere‐Ress Breakdown of academic impact, for papers by Robert A. Olie Breakdown of academic impact, for papers by Liubov Zaritskaya Breakdown of academic impact, for papers by R.C. Rees Breakdown of academic impact, for papers by Anja Krippner‐Heidenreich
Rankless by CCL
2026